5. Случай осложненной аутосомно-доминантнойполикистозной болезни почек

Авторы

  • Б. К. Исаматов JSC “National Scientific Center of Surgery named after A.N. Syzganova“, State Clinical Hospital “ The city emergency hospital of Almaty city“ Almaty, Kazakhstan
  • Г.М. Аденова State Clinical Hospital “ The city emergency hospital of Almaty city“ Almaty, Kazakhstan
  • Д.Б. Гебель State Clinical Hospital “ The city emergency hospital of Almaty city“ Almaty, Kazakhstan
  • Ғ.Қ. Әміров State Clinical Hospital “ The city emergency hospital of Almaty city“ Almaty, Kazakhstan
  • Б.Ж. Есенқұлов State Clinical Hospital “ The city emergency hospital of Almaty city“ Almaty, Kazakhstan
  • Р.А. Гасанов State Clinical Hospital “ The city emergency hospital of Almaty city“ Almaty, Kazakhstan

Загрузки

Аннотация

Аутосомно-доминантная поликистозная болезнь почек - наиболее распространенное наслед-ственное заболевание почек, выявляющийся у взрослых. Актуальность проблемы обусловлена осо-бенностью развития и роста кист, неспособностью существующих методов лечения предотвратить увеличение размеров кист и почек, прогрессирующее нарушение функции почек. В настоящей статье описана общая характеристика АДПБП, представлен анализ клинического случая осложненного тече-ния АДПБП.

Ключевые слова

аутосомно-доминантная по-ликистозная болезнь почек, поликистоз почек

Библиографические ссылки

  1. Lanktree MB, Haghighi A, Guiard E, et al. Preva-lence estimates of polycystic kidney and liver dis-ease by population sequencing. J Am Soc Nephrol 2018; 29: 2593–600
  2. Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant 2017; 32: 1356–63
  3. Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal dominant polycystic kid-ney and liver diseases. J Am Soc Nephrol 2018; 29: 13–23
  4. Heyer, C.M., Sundsbak, J.L., Abebe, K.Z., Chap-man, A.B., Torres, V.E., Grantham, J.J., Bae, K.T., Schrier, R.W., Perrone, R.D., Braun, W.E., et al.; HALT PKD and CRISP Investigators (2016). Pre-dicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correla-tions in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. Published online January 28, 2016. http://dx.doi. org/10.1681/ ASN.2015050583
  5. Porath, B., Gainullin, V. G., Cornec-Le Gall, E., Dillinger, E. K., Heyer, C. M., Hopp, K., Edwards, M. E., Madsen, C. D., Mauritz, S. R., Banks, C. J., Baheti, S., Reddy, B., and 16 others. Mutations in GANAB, encoding the glucosidase II-alpha sub-unit, cause autosomal-dominant polycystic kidney and liver disease. Am. J. Hum. Genet. 98: 1193-1207, 2016
  6. Basics Pathologists of diseases according to Rob-binson and Kotran, translated from English by Vi-nay Kumar, Abul K. Abbas, Nelson Rausto] [Pub-lished in Russian]. Publishing house “Logosphere” Moscow 2016 Volume 2
  7. E. M. Shilova, A. V. Smirnova, N. L. Kozlovskaya / Nephrology: wedge. rivers]. [Published in Rus-sian]. - M.: GEOTAR-Media, 2019 .—P.856
  8. Tareeva, I.E. Nephrology. A guide for doctors]. [Pub-lished in Russian] - M .: Medicine, 2011. —P. 688
  9. Rahman E, Niaz FA, Al-Suwaida A, Nahrir S, Bashir M, Rahman H, Hammad D. Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: A single center study. Saudi J Kidney Dis Transpl 2009;20:806-10. 10. [N. Yu. Kostenkov, S. S. Elgaitarova, M. O. Belush-enko, L. V. Borodina, P. V. Koroy]. Modern aspects of autosomal dominant polycystic kidney disease in adults. [Published in Russian] Bulletin of a young scientist, 2019.V.
  10. A.V. Smirnov, V.A. Dobronravov et al., Clinical rec-ommendations for the treatment and diagnosis of polycystic kidney disease] [Published in Russian] Research Institute of Nephrology, St. Petersburg State Medical University. Acad. I.P. Pavlova. -2015. - T. 19, No. 1. - S. 67-76

Опубликован

2019-12-01

Выпуск

№ 4 (2019)

Раздел

Статьи